By

My guest on today’s podcast says that while there were many successes in human development in 2017, arguably, the most significant achievements of the last 12 months were in global health. Public...

Chikungunya virus is a virus of the Togaviridae family, transmitted by Aedes mosquitoes, that causes acute febrile illness in infected humans. The virus was first isolated during an epidemic, originally...

While there have been no reported illnesses, out of an abundance of caution, Panera Bread is conducting a nationwide preemptive, voluntary recall of all 2 oz. and 8 oz. cream cheese products sold in its...

With New York facing a historic outbreak of influenza this season, U.S. Senator Charles E. Schumer today called on the Centers for Disease Control and Prevention (CDC) to designate a special ‘domestic...

By

This podcast is from a February 2015 radio interview with Sybil Meister. Sybil is the mother of  Koral Reef Meister Pier, a young lady from California who contracted the rarely encountered parasite, Balamuthia...

Public awareness campaigns on spotting the signs and symptoms of infectious diseases and how to prevent them, play a key role in helping to stop the spread of such infections, a new study in the journal Epidemiology...

Wilmington, MA pharmaceutical company,  CutisPharma announced today that the US Food and Drug Administration (FDA) has approved FIRVANQ™ (vancomycin hydrochloride) for oral solution, for the treatment...

According to the International Federation of Red Cross and Red Crescent Societies (IFRC), the Vice Minister of Public Health (MoPH) in North Korea officially informed the World Health Organization...

Last week, we reported on the Lassa fever outbreak in Nigeria where more than 100 cases have been reported since the beginning of the year. Of note in the report was ten health care workers have been infected...

By

Melinta Therapeutics, Inc. , a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today announced the U.S. launch of intravenous and oral formulations...